Cargando…

Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment

BACKGROUND: Intravitreal injection of medications is one of the most common procedures performed in ophthalmology. Intravitreal anti-VEGF agents are currently the chosen treatment for ocular fundus diseases, including age-related macular degeneration and diabetic retinopathy. As an invasive procedur...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreto, Renata, Cyrino, Francyne Veiga, Jorge, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678144/
https://www.ncbi.nlm.nih.gov/pubmed/33292734
http://dx.doi.org/10.1186/s40942-020-00258-5
_version_ 1783612097691648000
author Moreto, Renata
Cyrino, Francyne Veiga
Jorge, Rodrigo
author_facet Moreto, Renata
Cyrino, Francyne Veiga
Jorge, Rodrigo
author_sort Moreto, Renata
collection PubMed
description BACKGROUND: Intravitreal injection of medications is one of the most common procedures performed in ophthalmology. Intravitreal anti-VEGF agents are currently the chosen treatment for ocular fundus diseases, including age-related macular degeneration and diabetic retinopathy. As an invasive procedure it involves risks. The most serious complication from intravitreal injection of anti-VEGF agents is endophthalmitis (EO). Although rare, EO can result in devastating loss of vision. This article evaluates whether the use of an ultra-clean air flow (UA) can be another useful tool in the prevention of EOs. Accordingly, the maintenance of asepsis of the surgical field of intravitreal injections was verified with and without the use of UA. METHODS: The study was conducted in operating room of an ambulatory surgery center on four different surgical days when just intravitreal injections were scheduled. Two experiments using two Blood Agar and two Chocolate Agar plates (first 2 days; 4 plates by day) were carried out by positioning an UA directed to the surgical table and two other experiments (last 2 days; 4 plates per day) were carried out using similar plates without the use of the UA. All Blood Agar and four Chocolate Agar plates were positioned on the surgical table, close to the surgical filed. At the end of the day, after the conclusion of the intravitreous injections, the plates were sent for a biomolecular study that was carried out after 1 day of incubation at 37 °C. RESULTS: The sixteen plates, eight Blood Agar and eight Chocolate Agar, were analyzed qualitatively for the growth or not of microorganism’s colonies and identification of their species. The biomolecular study demonstrated the growth of bacteria of the genus Micrococcus sp. with the use of the UA and without the the UA bacterias of the genera Bacillus sp, Staphylococcus haemolyticus, Staphylococcus aureus and Staphylococcus cohnii ssp urealyticus were found. CONCLUSION: The use of UA close to the operating table prevented the growth of pathogenic bacteria and should be considered as an alternative tool to avoid the contamination of materials and drugs used for intravitreal injections.
format Online
Article
Text
id pubmed-7678144
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76781442020-11-20 Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment Moreto, Renata Cyrino, Francyne Veiga Jorge, Rodrigo Int J Retina Vitreous Original Article BACKGROUND: Intravitreal injection of medications is one of the most common procedures performed in ophthalmology. Intravitreal anti-VEGF agents are currently the chosen treatment for ocular fundus diseases, including age-related macular degeneration and diabetic retinopathy. As an invasive procedure it involves risks. The most serious complication from intravitreal injection of anti-VEGF agents is endophthalmitis (EO). Although rare, EO can result in devastating loss of vision. This article evaluates whether the use of an ultra-clean air flow (UA) can be another useful tool in the prevention of EOs. Accordingly, the maintenance of asepsis of the surgical field of intravitreal injections was verified with and without the use of UA. METHODS: The study was conducted in operating room of an ambulatory surgery center on four different surgical days when just intravitreal injections were scheduled. Two experiments using two Blood Agar and two Chocolate Agar plates (first 2 days; 4 plates by day) were carried out by positioning an UA directed to the surgical table and two other experiments (last 2 days; 4 plates per day) were carried out using similar plates without the use of the UA. All Blood Agar and four Chocolate Agar plates were positioned on the surgical table, close to the surgical filed. At the end of the day, after the conclusion of the intravitreous injections, the plates were sent for a biomolecular study that was carried out after 1 day of incubation at 37 °C. RESULTS: The sixteen plates, eight Blood Agar and eight Chocolate Agar, were analyzed qualitatively for the growth or not of microorganism’s colonies and identification of their species. The biomolecular study demonstrated the growth of bacteria of the genus Micrococcus sp. with the use of the UA and without the the UA bacterias of the genera Bacillus sp, Staphylococcus haemolyticus, Staphylococcus aureus and Staphylococcus cohnii ssp urealyticus were found. CONCLUSION: The use of UA close to the operating table prevented the growth of pathogenic bacteria and should be considered as an alternative tool to avoid the contamination of materials and drugs used for intravitreal injections. BioMed Central 2020-11-19 /pmc/articles/PMC7678144/ /pubmed/33292734 http://dx.doi.org/10.1186/s40942-020-00258-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Article
Moreto, Renata
Cyrino, Francyne Veiga
Jorge, Rodrigo
Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
title Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
title_full Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
title_fullStr Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
title_full_unstemmed Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
title_short Use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
title_sort use of an ultra-clean air flow for surgical field asepsis when performing intravitreous injections in an ambulatory surgical environment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678144/
https://www.ncbi.nlm.nih.gov/pubmed/33292734
http://dx.doi.org/10.1186/s40942-020-00258-5
work_keys_str_mv AT moretorenata useofanultracleanairflowforsurgicalfieldasepsiswhenperformingintravitreousinjectionsinanambulatorysurgicalenvironment
AT cyrinofrancyneveiga useofanultracleanairflowforsurgicalfieldasepsiswhenperformingintravitreousinjectionsinanambulatorysurgicalenvironment
AT jorgerodrigo useofanultracleanairflowforsurgicalfieldasepsiswhenperformingintravitreousinjectionsinanambulatorysurgicalenvironment